The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravisMartin Skov, Thomas Holm Pedersen, Anders Riisager et al.|Science Translational Medicine|2024Cited by 31
Neuromuscular transmission deficits in patients with <scp>CMT</scp> and <scp>ClC</scp>‐1 inhibition in <scp>CMT</scp> animal modelsThomas Skjærlund Grønnebæk, W. David Arnold, Helga Haahr‐Lillevang et al.|Annals of Clinical and Translational Neurology|2024Cited by 5